van der Poll T, Coyle S M, Moldawer L L, Lowry S F
Cornell University Medical College, Department of Surgery, New York, New York 10021, USA.
J Infect Dis. 1996 Dec;174(6):1356-60. doi: 10.1093/infdis/174.6.1356.
Whole blood of 6 healthy subjects, who were intravenously injected with lipopolysaccharide (LPS, 2 ng/kg), was stimulated ex vivo with LPS (10 ng/mL). Three and 6 h after injection of LPS, whole blood produced less tumor necrosis factor-alpha (TNF), interleukin (IL)-1beta, IL-6, and IL-10 (all P < .05). By contrast, the production of IL-1 receptor antagonist was enhanced after LPS injection (P < .05). Plasma obtained 2 h, but not 1 h, after in vivo administration of LPS showed a dose-dependent inhibition of TNF, IL-1beta, and IL-6 production by LPS-stimulated whole blood from 6 other healthy donors not previously exposed to LPS, while the production of IL-10 and IL-1 receptor antagonist were not or were marginally influenced. LPS tolerance represents a purposeful adaptation of the host, rather than a generalized hyporesponsiveness, and is at least partly mediated by soluble factors produced within 2 h after previous exposure to LPS.
对6名健康受试者静脉注射脂多糖(LPS,2 ng/kg),然后用LPS(10 ng/mL)对其全血进行离体刺激。注射LPS后3小时和6小时,全血产生的肿瘤坏死因子-α(TNF)、白细胞介素(IL)-1β、IL-6和IL-10均减少(均P < 0.05)。相比之下,注射LPS后IL-1受体拮抗剂的产生增强(P < 0.05)。在体内给予LPS后2小时(而非1小时)获得的血浆,对来自其他6名先前未接触过LPS的健康供体的LPS刺激全血中TNF、IL-1β和IL-6的产生呈剂量依赖性抑制,而IL-10和IL-1受体拮抗剂的产生未受影响或仅受到轻微影响。LPS耐受性代表宿主的一种有目的的适应性反应,而非普遍的低反应性,并且至少部分由先前接触LPS后2小时内产生的可溶性因子介导。